Minneapolis Portfolio Management Group’s Pfizer PFE Stock Holding History

Minneapolis Portfolio Management Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.3M	Buy	1,215,987 +7,142	+0.6%	+$187K	2.78%	23
2026 Q1	$33.9M	Buy	+1,208,845	New	+$32.2M	3.6%	13
2024 Q4	–	Sell	-950,151	Closed	-$27.5M	–	31
2024 Q3	$27.5M	Buy	950,151 +140,098	+17%	+$4.09M	3.56%	14
2024 Q2	$22.7M	Buy	+810,053	New	+$22.3M	3.07%	22
2021 Q1	–	Sell	-581,598	Closed	-$21.4M	–	32
2020 Q4	$21.4M	Sell	581,598 -26,212	-4%	-$961K	2.71%	20
2020 Q3	$21.2M	Buy	+607,810	New	+$21.3M	3.22%	16

Other funds holding PFE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Minneapolis Portfolio Management Group's PFE Position: Q2 2026 in Review

Minneapolis Portfolio Management Group increased its Pfizer (PFE) stake by 0.59% in Q2 2026, buying an estimated $187K and bringing the position to 1,215,987 shares worth $29.3M. The position accounts for 2.78% of the portfolio, ranked #23.

Minneapolis Portfolio Management Group first reported a position in PFE in Q3 2020 and has held it in 6 quarters since. The position peaked at $33.9M in Q1 2026. 1,496 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Minneapolis Portfolio Management Group held 1,215,987 shares of Pfizer worth $29.3M as of Q2 2026.
Minneapolis Portfolio Management Group bought 7,142 Pfizer shares in Q2 2026, an estimated $187K.
Pfizer made up 2.78% of Minneapolis Portfolio Management Group's portfolio in Q2 2026, its #23 holding.
Minneapolis Portfolio Management Group first reported a position in Pfizer in Q3 2020 and has held it in 6 quarters since.
Minneapolis Portfolio Management Group's Pfizer position peaked at $33.9M in Q1 2026.
1,496 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Minneapolis Portfolio Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.